Exhibit 99.1

| | | | | | |
| | KPMG Audit | | Téléphone : | | +33 (0)4 37 64 76 00 |
| | 51, rue de Saint-Cyr | | Télécopie : | | +33 (0)4 37 64 76 09 |
| | CS 60409 | | Site internet : | | www.kpmg.fr |
| | 69338 Lyon Cedex 09 | | | | |
| | France | | | | |
Independent Auditors’ Report
The President
Movea S.A.S.:
Report on the Financial Statements
We have audited the accompanying consolidated financial statements of Movea S.A.S and its subsidiary, which comprise the consolidated balance sheet as of December 31, 2013, and the related consolidated statement of operations and cash flows for the year then ended, and the related notes to the consolidated financial statements.
Management’s Responsibility for the Financial Statements
Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with French generally accepted accounting principles; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
Auditors’ Responsibility
Our responsibility is to express an opinion on these consolidated financial statements based on our audit. We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the consolidated financial statements. The procedures selected depend on the auditors’ judgment, including the assessment of the risks of material misstatement of the consolidated financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the consolidated financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
| | | | | | |
| | KPMG S.A. cabinet français membre de KPMG International, une coopérative de droit suisse | | Société anonyme d’expertisecomptable - commissariat aux comptes à directoire et conseil de surveillance. Inscrite au Tableau de l’ordre àParis sous le n° 14-30080101 et à la Compagnie des Commissaires aux Comptes de Versailles, | | Siège social ; KPMG S.A. Immeuble lé Palatin 3, cours du Triangle 92939 Paris La Défense Cedex Capital : 5 497 100 € Code APE 6920 Z 775726417 R.C.S. Nanterre TVA Union Européenne FR 77 775 726 417 |

Opinion
In our opinion, the consolidated financial statements referred to above present fairly in all material respects, the financial position of Movea S.A.S and its subsidiary as of December 31, 2013, and the results of their operations and their cash flows for the year then ended in accordance with French generally accepted accounting principles.
Emphasis of Matters
As discussed in Note 2)a) to the consolidated financial statements, no comparative financial information is presented as these consolidated financial statements are prepared for the first time and solely for the purpose of Invensense International Inc. which, in accordance with Rule 3-05 of regulation S-X, is required to present only one year of Movea S.A.S audited consolidated financial statements. Our opinion is not modified with respect to this matter.
Accounting principles generally accepted in France vary in certain significant respects from accounting principles generally accepted in the United States of America. Information relating to the nature of such differences is presented in Note 23 to the consolidated financial statements.
Lyon, France
August 4, 2014
KPMG Audit
A division of KPMG S.A.

Stéphane Devin
Partner
Movea S.A.
Consolidated Financial Statements
Year ended December 31, 2013
1/22
Table of Contents
| | | | |
| | Page | |
| |
Consolidated Balance Sheet | | | 3 | |
| |
Consolidated Statement of Operations | | | 4 | |
| |
Consolidated Statement of Cash Flows | | | 5 | |
| |
Notes to the Consolidated Financial Statements | | | 6 | |
2/22
Consolidated Balance Sheet
| | | | |
(in €) | | December 31, 2013 | |
| |
Assets | | | | |
Fixed Assets | | | | |
Intangible assets (note 3) | | | 467,586 | |
Property, plant and equipment (note 3) | | | 191,010 | |
Deposits (note 3) | | | 37,022 | |
| | | | |
Total Fixed Assets | | | 695,618 | |
| | | | |
| |
Current Assets | | | | |
Trade accounts receivable, net (note 5) | | | 829,671 | |
Inventories, net (note 4) | | | 23,758 | |
Other receivables (note 6) | | | 2,296,403 | |
Prepaid expenses | | | 110,337 | |
Cash and cash equivalents (note 8) | | | 1,150,607 | |
Total Current Assets | | | 4,410,776 | |
| | | | |
| | | | |
| | | | |
| |
Total Assets | | | 5,106,394 | |
| | | | |
| |
Shareholders’ Equity and Liabilities | | | | |
Shareholders’ Equity (note 9) | | | | |
Share capital | | | 296,348 | |
Additional paid-in capital | | | 16,271,353 | |
Accumulated deficit | | | (12,071,375 | ) |
Exchange translation difference | | | 13,395 | |
Net income (loss) | | | (4,305,516 | ) |
| | | | |
Total Shareholders’ Equity | | | 204,205 | |
| | | | |
| |
Liabilities | | | | |
Provisions (note 10) | | | 152 | |
Interest free debt (note 11) | | | 1,512,270 | |
Financial debt (note 11) | | | 711,639 | |
Trade accounts payable and accrued expenses (note 12) | | | 1,400,135 | |
Deferred revenue (note 2 r)) | | | 307,013 | |
Other liabilities (note 13) | | | 970,980 | |
| | | | |
Total Liabilities | | | 4,902,189 | |
| | | | |
| |
Total Shareholders’ Equity and Liabilities | | | 5,106,394 | |
| | | | |
See accompanying notes to consolidated financial statements
3/22
Consolidated Statement of Operations
| | | | |
(in €) | | Year ended December 31, 2013 | |
| |
Revenues (note 16) | | | 2,281,259 | |
Other operating income (note 17) | | | 857,626 | |
| | | | |
Total revenues | | | 3,138,885 | |
| | | | |
| |
Purchase of merchandise | | | 63,692 | |
Other external costs | | | 3,521,391 | |
Personnel costs, including social charges (note 18) | | | 4,566,074 | |
Taxes other than income tax | | | 62,170 | |
Depreciation and amortization expense, | | | 367,194 | |
Release of provisions net of allowances | | | (88,146 | ) |
| | | | |
Total operating expenses | | | 8,492,375 | |
| | | | |
Operating income (loss) | | | (5,353,490 | ) |
| | | | |
| |
Financial income | | | 16,496 | |
Financial expense | | | 93,876 | |
| | | | |
Net financial income (expense) (note 20) | | | (77,380 | ) |
| | | | |
| |
Net extraordinary income (expense) | | | (17,968 | ) |
| | | | |
| |
Income (loss) before income taxes | | | (5,448,838 | ) |
| | | | |
| |
Income tax expense (credit) (note 7) | | | (1,143,322 | ) |
| | | | |
| |
Net income (loss) | | | (4,305,516 | ) |
| | | | |
Net loss per share: | | | | |
Basic | | | (0.15 | ) |
Diluted (note 2q) | | | (0.15 | ) |
See accompanying notes to consolidated financial statements.
4/22
Consolidated Statement of Cash Flows
| | | | |
(in €) | | Year ended December 31, 2013 | |
Cash flows – operating activities: | | | | |
Net income (loss) | | | (4,305,516 | ) |
Adjustments to reconcile net loss to net cash used for operating activities: | | | | |
Depreciation & amortization expense | | | 303,219 | |
Changes in provisions | | | (24,171 | ) |
Deferred income taxes | | | (3,846 | ) |
Changes in working capital | | | | |
Changes in working capital | | | (305,953 | ) |
| | | | |
Net cash used for operating activities | | | (4,333,267 | ) |
| | | | |
Cash flows – investing activities: | | | | |
Capital expenditures – intangible assets | | | (14,355 | ) |
Capital expenditures – property, plant and equipment | | | (163,181 | ) |
Proceeds from disposals of investments | | | 3,079 | |
| | | | |
Net cash used for investing activities | | | (174,457 | ) |
| | | | |
Cash flows – financing activities: | | | | |
Proceeds from increase in share capital | | | 2,499,997 | |
Net changes in financial loans | | | 9,789 | |
Proceeds from R&D refundable advances | | | 1,005,584 | |
| | | | |
Net cash provided by financing activities | | | 3,515,370 | |
| | | | |
Effect of exchange rate changes on cash and cash equivalents | | | 157,708 | |
| | | | |
Change in cash and cash equivalents | | | (837,646 | ) |
| | | | |
| |
Cash and cash equivalents, beginning of period | | | 1,988,253 | |
Cash and cash equivalents, end of period | | | 1,150,607 | |
See accompanying notes to consolidated financial statements.
5/22
Notes to the Consolidated Financial Statements
| 1) | Company Legal Structure, Nature of Business and Significant Events |
Company Legal Structure
Movea is a French limited liability company (Société Anonyme) with a Board of Directors, subject to the provisions of the French Code of Commerce.
Nature of Business
The Company commercializes its technology, which turns sensor data into meaningful information, in the form of licenses or royalties, and provides subsequent development and support services to its customers. Its target markets are digital TV (“DTV” - connected TVs and set-top boxes), sports (specific products such as the Babolat racquet or standard wearable devices) and mobile (the Movea Sensorhub product range).
Revenue in 2013 is mainly derived from DTV business, but the mobile market is growing.
Significant Events of the Period
Following the second tranche of funding decided in July 2012, proceeds from a capital increase amounting to € 2.5 million were received in June 2013
Significant Subsequent Events
InvenSense has completed the acquisition of Movea SA on July 22, 2014. On that date the Company’s legal structure was changed from a S.A. “Société Anonyme” to a S.A.S. “Société par Actions Simplifiée”. As a result of this change, the Company no longer has a Board of Directors and is now headed by a President.
On July 30, 2014 Invensense issued a letter of support to Movea S.A whereby Invensense confirmed that it is their intention, as long as the Company remains within the Invensense Group, to continue to support the Company, if need be, so as to enable it to meet its liabilities as they fall due and to carry on its normal business without any significant curtailment to operations. The Company relied on the terms of this letter to close the consolidated financial statements of the Company as of and for the year ended December 31, 2013 on a going concern basis.
| 2) | Summary of Significant Accounting Policies and Methods |
| a) | Under French law Movea S.A. has never been required to prepare consolidated financial statements. These consolidated financial statements have been prepared voluntarily for the first time in the context of the acquisition of Movea and its subsidiaries (individually or collectively referred to as the “Company”) by Invensense International Inc. in July 2014. |
The consolidated financial statements of Movea for the year ended December 31, 2013 have been prepared in accordance with generally accepted accounting principles in France, including Rule 99-02 of the French Accounting Standards Board(Comité de la Réglementation Comptable - CRC).
No comparative financial information is presented as these consolidated financial statements are prepared for the first time and solely for the purpose of Invensense International Inc. which, in accordance with Rule 3-05 of regulation S-X, is required to present only one year of Movea S.A. audited consolidated financial statements.
6/22
Entities subject to control by the Company (depending principally on voting rights of more than 50%) have been included in the consolidated financial statements.
The list of entities included in the consolidated financial statements is as follows:
| | | | | | | | |
Name | | Registered office | | Control % | | | Method of consolidation |
| | | |
Movea S.A. | | Grenoble | | | N/A | | | Parent company |
Movea Inc | | San Francisco | | | 100 | % | | Fully consolidated |
The Company opened a branch office in South Korea in August 2013. The corresponding expenses are directly included in the financial statements of Movea S.A. since the branch office is not an independent legal entity.
The preparation of financial statements in conformity with French generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the balance sheet date and of revenue and expenses during the period. Actual results could differ from those estimates.
Significant estimates, judgments and assumptions made on the basis of information available at the reporting date mainly concern revenue recognition (note i) and research and development project subsidies (note j).
| c) | Translation of Foreign Subsidiaries’ Financial Statements |
The balance sheet and statements of operations and cash flows of Movea Inc., whose functional currency is the US dollar, are translated into the reporting currency of Movea S.A. (Euro) at the applicable exchange rates (i.e., the closing rate for balance sheet items, and the average annual rate for statements of operations and cash flows items). Resulting translation gains and losses are recorded in the foreign currency translation adjustment in shareholders’ equity.
| d) | Property, Plant and Equipment and Intangible Assets |
Property, plant and equipment and intangible assets are stated at their acquisition cost. Depreciation and amortization are computed principally using the straight-line method based on the estimated useful lives of the related assets. Estimated useful lives are as follows:
| | |
| | Estimated useful lives |
| |
Intangible Assets | | |
Patents | | 10 years |
Licenses | | 3 to 5 years |
Software | | 1 year |
| |
Property, plant and equipment | | |
Industrial machinery and equipment | | 3 to 4 years |
Leasehold improvements | | 4 to 5 years |
IT equipment | | 2 to 4 years |
Furnitures | | 3 to 4 years |
7/22
Raw materials and merchandise are recorded at purchase cost.
Finished goods and work in progress are recorded at their production cost.
When applicable, an inventory depreciation equal to the excess of the gross value determined in the manner indicated above and estimated net realizable value is accounted for.
| f) | Accounts Receivable, Net |
Accounts receivable are recorded at their nominal value. A provision is recorded when the recoverable amount is lower than the carrying amount on a case by case analysis.
| g) | Cash and Cash Equivalents |
Cash and cash equivalents include cash balances and short-term highly liquid investments with original maturities of three months or less at the time of purchase and are stated at cost.
Contingencies and charges arising from claims, litigation, fines, etc. are provided for when an obligation exists at balance sheet date, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation.
Movea revenue model is to license its technology/software (technology access fees or license fees), adapt the client’s environment to fit in the technology (service/porting fees) and collect royalties on the products which are sold to end users and include Movea technology.
Software licenses:
Software revenue results from Royalties and/or from Technology Access Fees.
Royalties are recognized:
| • | | upon the delivery of or access to the license when the royalty is fixed (without any relation to the volumes sold), is non-refundable, and is with no further commitment of the Company in this respect with regard to its customer (pre-paid royalties), or |
| • | | based on the statements reported by the customers when the royalty is calculated on volumes sold. In addition, royalties on volumes for which the Company has not yet obtained the customer statement are accrued, as estimated by the Company (post-paid royalties). |
Technology access fees are recognized in accordance with the terms of the contract, usually upon delivery of the software or access to the technology, as the Company has made full performance and has no further commitment to the customer.
Services
Revenue for services is recognized using the percentage of completion method, based on the milestones defined in the contract or, if no milestones are defined, based on the number of days worked over the total estimated number of days necessary to complete the services.
Maintenance fees are recognized on a pro-rata basis over the term of the contract.
The respective amounts of revenue allocated to each element are as stated in the contract.
8/22
Products or parts:
Movea may occasionally sell products or parts. Revenue is recognized upon shipment, in conformity with incoterm conditions.
| j) | Research & Development (“R&D”) Expenditure |
Accounting policy
All research costs are expensed as incurred. The Company elected not to capitalize development expenditures.
Subsidies
The Company receives R&D subsidies for its participation in R&D consortium projects. Income on R&D subsidies is recognized on a percentage of completion basis over the duration of the corresponding projects. Engineers record their time using dedicated software, which gives the combination of time spent and status of deliverables enabling the calculation of the percentage of completion on each project.
Income recognized does not correspond to the amount of subsidies received during the year, which depends on each project’s payment plan. The shortfall of the accumulated cash received over the income recognized on subsidized R&D projects based on the percentage of completion is booked to other receivable. The excess of the accumulated cash received over the income recognized on subsidized R&D projects based on the percentage of completion is booked to other liability.
Conditional refundable advances
The Company may also receive conditional refundable advances in combination with R&D consortium projects subsidies. These advances will be reimbursed and bear interest only if the outcome of the corresponding R&D project generates revenue. Such advances are initially accounted for as debt for the amount received and will be recognized to income if and when it becomes certain that the repayment conditions are not met. No interest is accrued until it is probable that repayment conditions are met.
France: Employee benefits (principally sickness and pensions) are managed through periodic contributions to French Social Security and do not require any accrual.
The Company is also required to pay retirement indemnities to employees, in accordance with French law, based on the length of service and final salary. The benefit is paid as a lump-sum at retirement and is expressed as a multiple of monthly salary.
The principal assumptions used in the determination of such benefits (under the prospective method) are described below:
| • | | Annual increase in salary: 2%; |
| • | | Employee retirement age : 62 years; |
| • | | Annual discount rate : 2.25%; |
| • | | Mortality: French national statistical institute (INSEE) mortality table TV 88/90. |
The Company has opted not to accrue for this lump-sum retirement benefits (approximately € 20 000 at December 31, 2013).
9/22
| l) | Income Tax, Current and Deferred |
Deferred taxes are recorded in the statement of operations and the balance sheet using the liability method in respect of temporary differences between the book and taxable values of certain assets and liabilities.
Tax benefits resulting from tax loss carry-forwards are recognized if it is more likely than not that they will be recovered within the foreseeable future.
| m) | Share-Based Compensation |
The Company has issued warrants (“BSA” and “BSPCE”) and stock options (“SO”). Under French rules:
| • | | The amounts received by the Company upon issuance of the “BSA, BSPCE and SO” warrants are accounted for in shareholders’ equity ; |
| • | | No other entry is recorded in the accounts as long as the warrants or stock options have not been exercised. |
Extraordinary items are:
| • | | either ordinary items of abnormal amount and occurrence; or |
| • | | items with the following characteristics : |
| • | | Unusual compared with the economic activity of the entity. |
| o) | Foreign Exchange Differences |
At the year-end, assets and liabilities denominated in foreign currencies are converted to Euros using the closing exchange rate. Resulting gains or losses are recorded in the consolidated statement of operations.
As an exception to this method, the exchange differences on an item that, in substance, forms part of the net investment in a consolidated foreign subsidiary are included in equity until the disposal or liquidation of the net investment. This applies to debt payable or receivable for which settlement is neither planned nor expected in the foreseeable future and which constitutes in substance an increase or decrease in the net investment of the group in this foreign enterprise
Basic earnings per share corresponds to the net income or loss divided by the weighted-average number of shares outstanding during the financial period (see note 9).
Diluted earnings per share is the division of the net income by the sum of the weighted-average number of shares outstanding and the maximal number of shares that may be issued on exercise of warrants or stock options (see note 9).
If the result for the year is a loss, diluted earnings per share is equal to basic earnings per share in accordance with the OEC’s French accounting opinion # 27 § 3.
| q) | Prepaid Expenses and Deferred Revenue |
Prepaid expenses concern only operating expenses.
Deferred revenue concern sales invoices for which revenue recognition has been deferred.
10/22
There is only one operating segment in the Group and its performance is shown in the consolidated statement of operations.
Intangible assets and Property, plant and equipment are as follows at December 31, 2013:
| | | | | | | | | | | | |
December 31, 2013 (€) | | Gross value | | | Accumulated depreciation and amortization | | | Net book value | |
Intangible Assets | | | | | | | | | | | | |
Licenses, Patents & Software | | | 1,774,674 | | | | 1,307,088 | | | | 467,586 | |
| | | | | | | | | | | | |
Total | | | 1,774,674 | | | | 1,307,088 | | | | 467,586 | |
| | | |
Property, plant and equipment | | | | | | | | | | | | |
Industrial machinery and equipment | | | 68,407 | | | | 63,533 | | | | 4,874 | |
Leasehold improvements | | | 85,197 | | | | 12,298 | | | | 72,899 | |
IT equipment | | | 208,794 | | | | 132,604 | | | | 76,190 | |
Furniture | | | 80,864 | | | | 43,817 | | | | 37,047 | |
| | | | | | | | | | | | |
Total | | | 443,262 | | | | 252,252 | | | | 191,010 | |
| | | | | | | | | | | | |
The net book value of intangible assets is mainly composed of the Technicolor license (€ 448,000) at December 31, 2013.
Changes in the gross values of fixed assets were as follows:
| | | | | | | | | | | | | | | | |
(€) | | At December 31, 2012 | | | Additions | | | Disposals | | | At December 31, 2013 | |
Licenses, patents and software | | | 1,760,319 | | | | 14,355 | | | | 0 | | | | 1,774,674 | |
| | | | | | | | | | | | | | | | |
Total Intangible assets | | | 1,760,319 | | | | 14,355 | | | | 0 | | | | 1,774,674 | |
| | | | | | | | | | | | | | | | |
| | | | |
| | At December 31, 2012 | | | Additions | | | Disposals | | | At December 31, 2013 | |
Industrial machinery and equipment | | | 68,407 | | | | 0 | | | | 0 | | | | 68,407 | |
Leasehold improvements | | | 44,636 | | | | 85,197 | | | | 44,636 | | | | 85,197 | |
IT equipment | | | 186,941 | | | | 61,004 | | | | 39,151 | | | | 208,794 | |
Furniture | | | 76,354 | | | | 16,980 | | | | 12,470 | | | | 80,864 | |
| | | | | | | | | | | | | | | | |
Total Property, plant and equipment | | | 376,337 | | | | 163,181 | | | | 96,256 | | | | 443,262 | |
| | | | |
| | At December 31, 2012 | | | Additions | | | Disposals | | | At December 31, 2013 | |
Deposits | | | 33,700 | | | | 3,322 | | | | 0 | | | | 37,022 | |
| | | | | | | | | | | | | | | | |
| | | | |
Total | | | 2,170,356 | | | | 180,858 | | | | 96,256 | | | | 2,254,958 | |
| | | | | | | | | | | | | | | | |
Main additions in 2013 result from:
• | | intangible assets: software licenses for R&; |
• | | property, plant and equipment: fitting out of Movea SA new offices and acquisition of furniture. |
11/22
Main disposals in 2013 result from:
• | | property, plant and equipment: disposal of leasehold improvements of the former offices in France and California. Furniture was also disposed of in California since the new office is fully furnished. |
Changes in accumulated depreciation and amortization were as follows:
| | | | | | | | | | | | | | | | |
(€) | | At December 31, 2012 | | | Amortization expense | | | Release on disposal | | | At December 31, 2013 | |
Licenses, patents and software | | | 1,031,841 | | | | 275,247 | | | | 0 | | | | 1,307,088 | |
| | | | | | | | | | | | | | | | |
Total Intangible assets | | | 1,031,841 | | | | 275,247 | | | | 0 | | | | 1,307,088 | |
| | | | | | | | | | | | | | | | |
| | | | |
| | At December 31, 2012 | | | Depreciation expense | | | Release on disposal | | | At December 31, 2013 | |
Industrial machinery and equipment | | | 52,083 | | | | 11,451 | | | | 0 | | | | 63,534 | |
Leasehold improvements | | | 20,303 | | | | 14,624 | | | | 22,628 | | | | 12,198 | |
IT equipment | | | 122,407 | | | | 49,045 | | | | 38,850 | | | | 132,602 | |
Furniture | | | 33,597 | | | | 16,827 | | | | 6,607 | | | | 43,817 | |
| | | | | | | | | | | | | | | | |
Total Property, plant and equipment | | | 228,390 | | | | 91,947 | | | | 68,085 | | | | 252,252 | |
| | | | | | | | | | | | | | | | |
| | | | |
Total | | | 1,260,231 | | | | 367,194 | | | | 68,085 | | | | 1,559,340 | |
| | | | | | | | | | | | | | | | |
Inventories are as follows at December 31, 2013:
| | | | | | | | | | | | |
December 31, 2013 (€) | | Gross Value | | | Inventory depreciation | | | Net Book Value | |
Raw materials, consumables | | | 36,043 | | | | 18,022 | | | | 18,021 | |
Merchandise | | | 45,509 | | | | 45,509 | | | | 0 | |
Finished goods | | | 5,737 | | | | 0 | | | | 5,737 | |
| | | | | | | | | | | | |
Total | | | 87,289 | | | | 63,531 | | | | 23,758 | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | At December 31, 2012 | | | Additions | | | Utilizations and reclassifications | | | At December 31, 2013 | |
Change in inventory depreciation | | | 65,695 | | | | 0 | | | | 2,164 | | | | 63,531 | |
| | | | | | | | | | | | | | | | |
The inventory reserve represents 50% of raw materials, consumables and 100% of merchandises.
12/22
| 5) | Trade Accounts Receivable, Net |
Trade accounts receivable are as follows at December 31, 2013:
| | | | |
(€) | | December 31, 2013 | |
Trade accounts receivable (invoices issued) | | | 851,455 | |
Allowance for doubtful accounts | | | (21,784 | ) |
| | | | |
Net | | | 829,671 | |
| | | | |
| | | | | | | | | | | | | | | | |
(€) | | At December 31, 2012 | | | Additions | | | Utilizations and reclassifications | | | At December 31, 2013 | |
Change in bad debt allowance | | | 92,131 | | | | 21,784 | | | | 92,131 | | | | 21,784 | |
| | | | | | | | | | | | | | | | |
The bad debt allowance concerns a receivable from customer Kaser.
Other receivables were as follows at December 31, 2013:
| | | | |
(€) | | December 31, 2013 | |
Deferred tax | | | 3,998 | |
Social charges receivable | | | 11,182 | |
Tax receivable | | | 214,514 | |
Tax credit (including R&D tax credit) | | | 1,173,586 | |
Advances to suppliers | | | 8,004 | |
Other income receivable | | | 885,119 | |
| | | | |
Total | | | 2,296,403 | |
| | | | |
Research Tax Credit
In France, companies are entitled to claim a research tax credit which is based on eligible R&D costs incurred by the Company. Movea has applied for such a credit. As a general rule, the tax credit can be deducted from the income tax liability during a period of three years, or reimbursed by the tax authorities after the three year period if not utilized or earlier if the Company meets certain criteria. Specifically, Movea qualifies as a JEI (Jeune Entreprise Innovante) under French rules, which allows the Company to request the immediate reimbursement of the tax credit.
Under current French law, the immediate reimbursement will be maintained as long as Movea has less than 250 employees and generates revenue of under € 50 million.
The reimbursement usually occurs in April or May of the following year.
The 2012 research tax credit was received in 2013, amounting to €1,225,000
As of December 31, 2013 the following tax credits were recorded, totaling €1,173,586:
• | | € 1,100,000 for the research tax credit; |
• | | € 32,752 for the “competitiveness” tax credit (CICE); |
• | | € 34,434 for the “innovation” tax credit; |
• | | € 6,400 for the apprenticeship tax credit. |
All these tax credits were received in the second quarter of 2014.
13/22
In accordance with French GAAP the tax credits are recorded in the income statement as income tax credit (except for the CICE which is recorded within personnel costs) in the year the underlying eligible expenses are incurred.
Other Income Receivable
This represents the shortfall of the accumulated cash received over the income recognized on subsidized R&D projects based on the percentage of completion (see note 2 j)).
The income tax expense (credit) consists of the following:
| | | | |
(€) | | 31 December 2013 | |
Current income tax (credit) | | | (1,139,476 | ) |
Deferred income tax (credit) | | | (3,846 | ) |
| | | | |
Total | | | (1,143,322 | ) |
| | | | |
Deferred tax assets at December 31, 2013 are as follows:
| | | | |
(€) | | December 31, 2013 | |
Tax losses carried forward | | | 0 | |
Other temporary differences | | | 3,846 | |
| | | | |
Net deferred tax asset | | | 3,846 | |
| | | | |
As at December 31, 2013 the Company had €15,201,983 from Movea SA and $7,473,837 (€5,419,358) from Movea Inc. of accumulated net operating losses that are available to offset future taxable income and which may be carried forward indefinitely.
No deferred tax asset resulting from these loss carry forwards has been recognized at December 31, 2013 as it is not considered likely that they will be recovered within the foreseeable future.
Income tax expense (credit) in 2013 differed from the amount computed by applying the French statutory income tax rate of 33.33% to pre-tax income (loss), as a result of the following:
| | | | |
(€) | | December 31, 2013 | |
Loss before income taxes: | | | (5,448,838 | ) |
| | | | |
Expected income tax expense (credit) at French statutory tax rate | | | (1,816,098 | ) |
Research tax credit | | | (1,100,000 | ) |
Income tax Movea Inc. | | | 1,358 | |
Unrecognized deferred tax assets on tax loss for the year | | | 1,848,850 | |
Other tax credits | | | (73,586 | ) |
| | | | |
Actual income tax expense (credit) | | | (1,139,476 | ) |
| | | | |
In France, companies may benefit from tax credits based on the research costs of the year (see note 6).
14/22
| 8) | Cash and Cash Equivalents |
Cash and cash equivalents as at December 31, 2013 are composed of the following bank balances:
Changes in shareholders’ equity over the year ended December 31, 2013 are as follows :
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Share capital | | | Additional Paid In Capital | | | Retained Earnings | | | Foreign Currency Translation Adjustment | | | Total Stockholders equity | |
| | No shares | | | € | | | € | | | € | | | € | | | € | |
At December 31, 2012 | | | 26 063 376 | | | | 260,634 | | | | 13,807,070 | | | | (12,071,375 | ) | | | 54,907 | | | | 2,051,236 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Increase in share capital through exercise of warrants | | | 3 571 425 | | | | 35,714 | | | | 2,464,283 | | | | | | | | | | | | 2,499,997 | |
Foreign exchange translation | | | | | | | | | | | | | | | | | | | (41,512 | ) | | | (41,512 | ) |
Net loss | | | | | | | | | | | | | | | (4,305,516 | ) | | | | | | | (4,305,516 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | |
At December 31, 2013 | | | 29 634 801 | | | | 296,348 | | | | 16,271,353 | | | | (16,376,891 | ) | | | 13,395 | | | | 204,205 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
General
The Company was incorporated in 2007; Additional shares were issued for cash in subsequent financing operations and through exercise of warrants. At December 31, 2013, the issued share capital consisted of 6 000,000 common shares and 23,634,801 preferred shares, with a par value of € 0.01.
Pre-emptive Subscription Rights
Shareholders and certain directors have pre-emptive rights to subscribe for additional shares issued by the Company for cash on apro rata basis. Shareholders may waive such pre-emptive subscription rights at an extraordinary general meeting of shareholders under certain circumstances. Pre-emptive subscription rights, if not previously waived, are transferable during the subscription period relating to a particular offer of shares.
The Company has issued warrants in the form of “BSA” Bons de souscription d’actions and “BSPCE” Bons de souscription de parts de créateur d’entreprise, and stock-options (“SO”).
The shareholders of Movea have authorized the board of directors to grant warrants and stock options to employees, members of the board of the French parent company and other contributors. Each BSA, BSPCE and SO entitles the holder to subscribe to one common share of Movea. For sake of simplification, BSA, BSPCE, and SO are collectively referred to hereafter as “options”.
| | | | | | | | | | | | | | | | |
Plan name | | BCE 0910 1 (obj) | | | BCE 0910 2 | |
Date | | Board dated Sept. 7, 2011 | | | Board dated Nov. 16, 2011 | | | Board dated May 18, 2011 | | | Board dated Sept. 7, 2011 | |
Total | | | 265 750 | | | | 15 000 | | | | 263 500 | | | | 565 750 | |
Exercise price | | | 0,54 | | | | 0,54 | | | | 0,54 | | | | 0,54 | |
End of validity | | | Sept 23, 2015 | | | | Sept 23, 2015 | | | | Sept 23, 2015 | | | | Sept 23, 2015 | |
| | | | |
Vesting conditions | | | on objective | | | | on objective | | | | over 4 years, 1/4 per year | | | | over 4 years, 1/4 per year | |
| | | | | | | | | | | | | | | | |
TOTAL GRANTED | | | 265 750 | | | | 15 000 | | | | 263 500 | | | | 565 750 | |
| | | | | | | | | | | | | | | | |
TOTAL FORFEITED/EXPIRED | | | 0 | | | | 0 | | | | 0 | | | | 0 | |
| | | | | | | | | | | | | | | | |
TOTAL VALID | | | 265 750 | | | | 15 000 | | | | 263 500 | | | | 565 750 | |
| | | | | | | | | | | | | | | | |
15/22
| | | | | | | | | | | | | | | | |
Plan name | | SO 0910 2 | | | SO 09101 (obj) | |
Date | | Board dated May 18, 2011 | | | Board dated Sept. 7, 2011 | | | Board dated Nov. 16, 2011 | | | Board dated Sept. 7, 2011 | |
Total | | | 104 000 | | | | 280 000 | | | | 68 000 | | | | 100 000 | |
Exercise price | | | 0,54 | | | | 0,54 | | | | 0,54 | | | | 0,54 | |
End of validity | | | Sept 23, 2015 | | | | Sept 23, 2015 | | | | Sept 23, 2015 | | | | Sept 23, 2015 | |
Vesting conditions | | | over 4 years, 1/4 per year | | | | over 4 years, 1/4 per year | | | | over 4 years, 1/4 per year | | | | on objective | |
| | | | | | | | | | | | | | | | |
TOTAL GRANTED | | | 104 000 | | | | 280 000 | | | | 68 000 | | | | 100 000 | |
| | | | | | | | | | | | | | | | |
TOTAL FORFEITED/EXPIRED | | | 0 | | | | 70 000 | | | | 0 | | | | 0 | |
| | | | | | | | | | | | | | | | |
| | | | |
TOTAL VALID | | | 104 000 | | | | 210 000 | | | | 68 000 | | | | 100 000 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Plan name | | BCE05 12 | | | BSA 0512 | | | SO 0512 | |
| | Board dated | | | Board dated | | | Board dated | | | Board dated | | | Board dated | | | Board dated | |
Date | | Sept. 18, 2012 | | | June 13, 2013 | | | Nov. 20, 2013 | | | Sept. 18, 2012 | | | Sept. 18, 2012 | | | Nov. 20, 2013 | |
Total | | | 396 000 | | | | 194 000 | | | | 918 000 | | | | 60 000 | | | | 15 000 | | | | 20 000 | |
Exercise price | | | 0,63 | | | | 0,63 | | | | 0,63 | | | | 0,63 | | | | 0,63 | | | | 0,63 | |
End of validity | | | June 15, 2017 | | | | June 15, 2017 | | | | June 15, 2017 | | | | June 15, 2017 | | | | June 15, 2017 | | | | June 15, 2017 | |
Vesting conditions | | | over 4 years 1/8 th every 6 months | | | | over 4 years 1/8 th every 6 months | | | | over 4 years 1/8 th every 6 months | | | | over 4 years, 1/4 per year | | | | over 4 years, 1/4 per year | | | | over 4 years, 1/4 per year | |
| | | | | | | | | | | | | | | | | | | | | | | | |
TOTAL GRANTED | | | 396 000 | | | | 194 000 | | | | 918 000 | | �� | | 60 000 | | | | 15 000 | | | | 20 000 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
TOTAL FORFEITED/EXPIRED | | | 30 000 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | | | | 0 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
TOTAL VALID | | | 366 000 | | | | 194 000 | | | | 918 000 | | | | 60 000 | | | | 15 000 | | | | 20 000 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
At December 31, 2013 all options have been granted.
Provisions amount to €152 as at December 31, 2013 and pertain to the following:
| | | | | | | | | | | | | | | | |
Change in provisions (€) | | At January 1, 2013 | | | Additions | | | Utilizations and reclassifications | | | At December 31, 2013 | |
Provision for warranty and litigation | | | 19,617 | | | | 0 | | | | 19,617 | | | | 0 | |
Provision for deferred tax | | | 0 | | | | 152 | | | | 0 | | | | 152 | |
| | | | | | | | | | | | | | | | |
Total | | | 19,617 | | | | 152 | | | | 19,617 | | | | 152 | |
| | | | | | | | | | | | | | | | |
Starting in September 2013, the Company has been subject to an examination by the French tax administration covering fiscal years 2010, 2011 and 2012. At the end of 2013 an assessment was sent to the Company for 2010 alone. The final 2010 assessment resulted in tax claimed of € 36,000 with a penalty of €19,000. These tax assessments are disputed by the Company. The Company did not book any provision considering that the argumentation of the Tax administration was not valid and that it would not result in a probable cash outflow.
The final assessments for 2011 and 2012 did not have any negative financial outcome.
16/22
| 11) | Conditional R&D advances and Financial Debt |
Financial debt consists in:
Bank loans
Bank loans at December 31, 2013 comprise two loans granted by BNP Paribas with outstanding balances amounting to €.709,789:
• | | loan of €.700,000 agreed in December 2012, repayable over 3 years. In 2013, repayments on this loan amounted to €.226,000. Then loan carries a fixed interest rate of 3.20%.; |
Security in the form of a pledge over Company goodwill in the amount of €.700,000 was granted in favor of BNP Paribas;
• | | loan of €.250,000 agreed in September 2013 repayable over 3 years. In 2013, repayments on this loan amounted to €.13,000. The loan carries a fixed interest rate of 3.30%. |
Conditional R&D refundable advances
R&D projects are funded either through subsidies or refundable advances which will be reimbursed only if the outcome of the corresponding R&D project generates revenue. The Company has two outstanding refundable advances at December 31, 2013, whose detailed terms and conditions for reimbursement are:
| | | | | | | | | | | | | | | | |
From | | Interest rate | | | Reimbursement over | | | As of dec 31, 2013 (€) | | | Terms of reimbursement | | Add-on |
| | | | | |
PRIIM-BPI | | | 2,45 | % | | | 5 years - yearly | | | | 1,113,529 | | | Starting in June 2014 if yearly turnover = 15 M€ Plan : 80 K€ in year 1, 140 K€ in year 2, 320 K€ in year 3, 440 K€ in year 4, 470 K€ in year 5 | | 0,8% of Priim only turnover estimate was 20% of total turnover. Cap : 3,7 M€ ends in 2020 |
| | | | | |
PVAA-BPI | | | 2,49 | % | | | 5 years - yearly | | | | 398,741 | | | Starting in 2015 if PVAA turnover=2 M€ Plan : 80 K€ in year 1, 90 K€ in year 2, 110 K€ in year 3, 110 K€ in year 4, 110 K€ in year 5 | | No |
| | | | | | | | | | | | | | | | |
Total | | | | | | | | | | | 1,512,266 | | | | | |
| | | | | | | | | | | | | | | | |
Notes:
Rate
The R&D refundable advances are interest-free. In case of reimbursement an interest rate will be applied, from the date the reimbursement starts and until its completion.
Terms for reimbursement
The R&D refundable advances will be reimbursed only if the conditions for reimbursement are met.
These conditions consist in revenue achievements, either revenue directly generated by the funded project, or total revenue of the Company.
In case of change of control, the funding entity can request anticipated reimbursement.
If the conditions are not met, the refundable advances are turned into subsidies and recorded to the statement of operations.
Add-on
In case of commercial success of the Priim project, additional commissions can be paid to the funding entity in excess of the advances amount.
17/22
| 12) | Trade Accounts Payable and Accrued Expenses |
Trade accounts payable and accrued expenses amount to €.1,400,135 as at December 31, 2013 and are broken down as follows:
| | | | |
(€) | | December 31, 2013 | |
Trade accounts payable | | | 1,321,135 | |
Trade accrued expenses | | | 79,000 | |
| | | | |
Total | | | 1,400,135 | |
| | | | |
Other liabilities amount to € 970,780 as at December 31, 2013 and can be broken down as follows:
| | | | |
(€) | | December 31, 2013 | |
Employees and social charge organizations | | | 679 950 | |
Other | | | 291,030 | |
| | | | |
Total | | | 970,780 | |
| | | | |
Employee-related payables include
• | | amounts due to employees: accrued vacation and accrued bonuses related to the second semester of 2013; |
• | | employer’s payroll contributions (payment of social contributions related to December and/or to the fourth quarter of 2013 was made in January 2014); |
• | | annual employer tax accruals (taxe d’apprentissage, formation continue, fongecif). |
Other includes:
• | | The excess of the accumulated cash received over the income recognized on subsidized R&D projects based on the percentage of completion is booked to other liability (see note 2 j)). |
18/22
| 14) | Maturity of Receivables and Liabilities |
The breakdown by maturity is as follows:
| | | | | | | | | | | | | | | | |
| | | | | Due in | |
(€) | | At December 31, 2013 | | | Less than 1 year | | | 1 to 5 years | | | More than 5 years | |
Assets | | | | | | | | | | | | | | | | |
Deposits | | | 37,022 | | | | 37,022 | | | | | | | | | |
Accounts receivable | | | 829,671 | | | | 829,671 | | | | | | | | | |
Other receivables | | | 2,296,406 | | | | 2,296,406 | | | | | | | | | |
Prepaid expense | | | 110,337 | | | | 110,337 | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Total | | | 3,273,436 | | | | 3,273,436 | | | | 0 | | | | 0 | |
| | | | | | | | | | | | | | | | |
| | | | |
Liabilities | | | | | | | | | | | | | | | | |
Interest free debt (*) | | | 1,512,266 | | | | 80,000 | | | | 1,322,266 | | | | 110,000 | |
Financial debt | | | 709,789 | | | | 317,025 | | | | 392,764 | | | | | |
Accrued interest | | | 1,850 | | | | 1,850 | | | | | | | | | |
Accounts payable | | | 1,400,135 | | | | 1,400,135 | | | | | | | | | |
Other liabilities | | | 970,980 | | | | 970,980 | | | | | | | | | |
Deferred revenue | | | 307,013 | | | | 307,013 | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Total | | | 4,902,033 | | | | 3,077,003 | | | | 1,715,030 | | | | 110,000 | |
| | | | | | | | | | | | | | | | |
(*) | If conditions for reimbursement are met. See note 11). |
The Company does not lease any significant facility or equipment under an operating or capital lease other than its offices in Grenoble, France and Pleasanton, California (annual rental expenses of €226,698 in 2013).
Revenue recognition policy is described in the note 2 i).
Revenues by country are as follows for the year ended December 31, 2013:
| | | | |
(€) | | 2013 | |
France | | | 772,258 | |
Other countries | | | 1,509,001 | |
| | | | |
Total | | | 2,281,259 | |
| | | | |
Deferred revenue at December 31, 2013 mainly consists in:
• | | prepaid royalties 2014 for customer Babolat. These royalties have been invoiced and paid 2013; |
• | | techno access license and prepaid royalties for customer Neurosky. These license and royalties have been invoiced in 2013, but final delivery of the license was not completed prior to year end. |
19/22
The Company receives R&D subsidies for its participation in R&D consortium projects. The R&D subsidies are recognized on a percentage of completion basis over the duration of the corresponding projects, representing income of € 847,842 in 2013 (see note 2��j)).
| 18) | Personnel costs, including social charges |
Gross employee remuneration and the Company’s related social charges amount to € 3,428,069 and € 1,138,005 respectively, for the year ended December 31, 2013.
Average headcount is as follows:
| | | | | | | | | | | | |
Total Headcount | |
| | 2013 | | | Movea SA | | | Movea Inc. | |
Company managers and Engineers | | | 43 | | | | 40 | | | | 3 | |
Other staff | | | 5 | | | | 3 | | | | 2 | |
Total | | | 48 | | | | 43 | | | | 5 | |
| | | | | | | | | | | | |
| 19) | Research and Development Expenditure |
The gross amount of research and development expenditure incurred by the Company for the year ended December 31, 2013 amounts to € 4.5 million, which represents 62% of total operating expenses.
These costs are only incurred in Movea SA (France). Movea Inc. has no research activity.
| 20) | Net Financial Income/Expense |
Financial income and expense in 2013 are detailed as follows:
| | | | |
(€) | | December 31, 2013 | |
Foreign exchange gains | | | 8,682 | |
Other financial income | | | 7,814 | |
| | | | |
Total financial income | | | 16,496 | |
| | | | |
| |
Foreign exchange losses | | | (47,941 | ) |
Interest | | | (45,936 | ) |
| | | | |
Total financial expense | | | (93,877 | ) |
| | | | |
Under the French accounting regulation n° 2010-02, we inform you that there are no significant transactions that have not been made under normal market conditions either with related parties or with shareholders or members of the board of directors.
20/22
| 22) | Remuneration of Senior Executives |
| | | | |
(€) | | 2013 | |
Board | | | 23,040 | |
Directors | | | 247,090 | |
| | | | |
| 23) | Summary of Differences between French GAAP and US GAAP |
The consolidated financial statements have been prepared in accordance with French GAAP which, as applied by the Company, differs in certain significant respects from accounting principles generally accepted in the United States of America (“US GAAP”).
Accounting for Revenue Recognition
Refer to note 2 i) for revenue recognition policy under French GAAP.
Under US GAAP, ASC Subtopic 985-605, Software - Revenue Recognition, provides the main authoritative guidance regarding revenue recognition for software transactions. Specifically:
• | | if an arrangement to deliver software or a software system, either alone or together with other products or services, requires significant production, modification, or customization of software, the entire arrangement should be accounted for in conformity with ASC Subtopic 605-35, Revenue Recognition - Construction-Type and Production-Type Contracts; |
• | | if contract accounting does not apply, ASC Subtopic 985-605, Software - Revenue Recognition, specifies four criteria that must be met prior to recognizing revenue for a single-element arrangement or for the individual elements within the scope of ASC Subtopic 985-605 in a multiple-element arrangement. The four revenue recognition criteria are set out in paragraph 985-605-25-3 as follows: |
| • | | Persuasive evidence of an arrangement exists; |
| • | | The vendor’s fee is fixed or determinable; |
| • | | Collectibility is probable |
In addition, the Company’s contracts usually include some or all of the following elements: software licenses, maintenance and support, integration services, technology access fees, and royalties. Such arrangements would qualify as multiple elements arrangements. Prior to applying the above guidance, these multiple element arrangements would need to be evaluated for separation under the guidance of ASC Subtopic 605-25. For elements within the scope of ASC Subtopic985-605, the fee should be allocated to the various elements based on vendor-specific objective evidence of fair value, regardless of any separate prices stated within the contract for each element. Vendor-specific objective evidence of fair value is limited to the following:
• | | The price charged when the same element is sold separately; |
• | | For an element not yet being sold separately, the price established by management having the relevant authority; it must be probable that the price, once established, will not change before introduction of the element into the marketplace. |
;
Share based payments
Under French GAAP, no compensation expense is recognized in connection with the grant of options.
Under US GAAP, these transactions are in the scope of ASC topic 718 concerning share base payments transactions with employees and ASC topic 505-50 for non employees. The Company has to measure goods or services received in a share-based payment transaction using a fair value-based measure. They are recognized over the period in which they are received and measured based on the grant-date fair value of the equity instruments granted.
21/22
R&D refundable advances
Refer to note 2 j) for recognition and measurement policy under French GAAP.
There is no specific US GAAP guidance on the accounting for grants and more specifically on the accounting for conditional R&D refundable advances from government sponsored agencies. Under US GAAP, according to ASC subtopic 30-10, loans received solely for cash are also generally initially measured based on the cash proceeds, which is similar to the initial accounting applied to conditional R&D refundable advances under French GAAP. Furthermore, according to the Company’s management, at the date these financial statements are approved, there are remote chances that the repayment conditions of conditional R&D refundable advances will ever be met. In these circumstances, no significant difference between French GAAP and US GAAP in the accounting for these conditional R&D refundable advances as of and for the year ended December 31, 2013 has been identified.
;
Research Tax Credit
As indicated in note 6, under French GAAP, the Research Tax Credit is booked as a credit to the income tax caption within the income statement.
Under US GAAP, the Research Tax Credit would qualify as a government grant as it involves the receipt of cash (refundable tax credit) by the Company for past research and development costs. The tax credit does not depend on current or future taxable income. ASC Topic 740 does not address accounting for government grants. However, in practice, under US GAAP, the Research Tax Credit would be accounted for within operating income.
Retirement indemnities
Movea S.A.S. employees are entitled to receive, on retirement, a lump sum payment as defined under the applicable industry collective wage agreement. As indicated in note 2 k) to these financial statements, the Company has opted not to accrue for this employees’ retirement indemnity obligation under French GAAP.
Under US GAAP, compensation cost for this retirement benefit should be recognized in the period in which the employee renders services and the Company should recognize on its consolidated balance sheet the present value of the projected benefit obligation determined by applying an actuarial valuation method.
22/22